GSA CAPITAL PARTNERS LLP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 92 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$154,000
+294.9%
486,568
+794.9%
0.02%
+300.0%
Q1 2022$39,000
-94.7%
54,370
-78.6%
0.01%
-93.3%
Q3 2021$733,000
+103.6%
254,376
+97.8%
0.08%
+27.1%
Q4 2020$360,000
+60.0%
128,626
+43.5%
0.06%
+55.3%
Q3 2020$225,000
+118.4%
89,663
+242.4%
0.04%
+171.4%
Q3 2019$103,000
+5.1%
26,187
+140.7%
0.01%
+133.3%
Q1 2016$98,00010,8810.01%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders